151 related articles for article (PubMed ID: 26653678)
21. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells.
Bock S; Pfalzgraff A; Weindl G
J Dermatol Sci; 2016 Apr; 82(1):9-17. PubMed ID: 26803226
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation.
Puttur FK; Fernandez MA; White R; Roediger B; Cunningham AL; Weninger W; Jones CA
J Immunol; 2010 Jul; 185(1):477-87. PubMed ID: 20519652
[TBL] [Abstract][Full Text] [Related]
23. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement.
Bock S; Murgueitio MS; Wolber G; Weindl G
Pharmacol Res; 2016 Mar; 105():44-53. PubMed ID: 26794428
[TBL] [Abstract][Full Text] [Related]
25. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
[TBL] [Abstract][Full Text] [Related]
26. Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response.
Zhang J; Burn C; Young K; Wilson M; Ly K; Budhwani M; Tschirley A; Braithwaite A; Baird M; Hibma M
Sci Rep; 2018 Feb; 8(1):2373. PubMed ID: 29402982
[TBL] [Abstract][Full Text] [Related]
27. IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.
Wolf GT; Moyer JS; Kaplan MJ; Newman JG; Egan JE; Berinstein NL; Whiteside TL
Onco Targets Ther; 2018; 11():3731-3746. PubMed ID: 29988729
[TBL] [Abstract][Full Text] [Related]
28. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20.
Caberg JH; Hubert P; Herman L; Herfs M; Roncarati P; Boniver J; Delvenne P
Cancer Immunol Immunother; 2009 Jan; 58(1):39-47. PubMed ID: 18438663
[TBL] [Abstract][Full Text] [Related]
29. Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections.
Leong CM; Doorbar J; Nindl I; Yoon HS; Hibma MH
J Invest Dermatol; 2010 Feb; 130(2):472-80. PubMed ID: 19759549
[TBL] [Abstract][Full Text] [Related]
30. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Deng L; Dai P; Ding W; Granstein RD; Shuman S
J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
[TBL] [Abstract][Full Text] [Related]
31. Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.
de Jong A; van der Hulst JM; Kenter GG; Drijfhout JW; Franken KL; Vermeij P; Offringa R; van der Burg SH; Melief CJ
Int J Cancer; 2005 Mar; 114(2):274-82. PubMed ID: 15540211
[TBL] [Abstract][Full Text] [Related]
32. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
[TBL] [Abstract][Full Text] [Related]
33. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
34. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous immune system].
Schmitt D
C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
[TBL] [Abstract][Full Text] [Related]
36. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
37. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Pinto LA; Edwards J; Castle PE; Harro CD; Lowy DR; Schiller JT; Wallace D; Kopp W; Adelsberger JW; Baseler MW; Berzofsky JA; Hildesheim A
J Infect Dis; 2003 Jul; 188(2):327-38. PubMed ID: 12854090
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.
Woodham AW; Raff AB; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():135-49. PubMed ID: 25348303
[TBL] [Abstract][Full Text] [Related]
39. Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.
Hubert P; van den Brüle F; Giannini SL; Franzen-Detrooz E; Boniver J; Delvenne P
Am J Pathol; 1999 Mar; 154(3):775-84. PubMed ID: 10079255
[TBL] [Abstract][Full Text] [Related]
40. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
Naylor PH; Hadden JW
Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
